2,594
Views
101
CrossRef citations to date
0
Altmetric
Point of View

Yin Yang 1

A multifaceted protein beyond a transcription factor

, , &
Pages 81-84 | Published online: 01 Sep 2010

References

  • Shi Y, Seto E, Chang LS, Shenk T. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 1991; 67:377 - 388
  • Donohoe ME, Zhang X, McGinnis L, Biggers J, Li E, Shi Y. Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol Cell Biol 1999; 19:7237 - 7244
  • Sui G. The Regulation of YY1 in Tumorigenesis and its Targeting Potential in Cancer Therapy. Mol Cell Pharmacol 2009; 1:157 - 176
  • Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function and therapeutic implications in cancer biology. Oncogene 2006; 25:1125 - 1142
  • Yant SR, Zhu W, Millinoff D, Slightom JL, Goodman M, Gumucio DL. High affinity YY1 binding motifs: identification of two core types (ACAT and CCAT) and distribution of potential binding sites within the human beta globin cluster. Nucleic Acids Res 1995; 23:4353 - 4362
  • Deng Z, Wan M, Cao P, Rao A, Cramer SD, Sui G. Yin Yang 1 regulates the transcriptional activity of androgen receptor. Oncogene 2009; 28:3746 - 3757
  • Thomas MJ, Seto E. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?. Gene 1999; 236:197 - 208
  • Wilkinson FH, Park K, Atchison ML. Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proc Natl Acad Sci USA 2006;
  • Luke MP, Sui G, Liu H, Shi Y. Yin Yang 1 physically interacts with HOXA11 and represses HOXA11-dependent transcription. J Biol Chem 2006;
  • Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P, et al. Yin Yang 1 is a negative regulator of p53.. Cell 2004; 117:859 - 872
  • Gronroos E, Terentiev AA, Punga T, Ericsson J. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci USA 2004; 101:12165 - 12170
  • Santiago FS, Ishii H, Shafi S, Khurana R, Kanellakis P, Bhindi R, et al. Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly. Circ Res 2007; 101:146 - 155
  • Palko L, Bass HW, Beyrouthy MJ, Hurt MM. The Yin Yang-1 (YY1) protein undergoes a DNA-replication-associated switch in localization from the cytoplasm to the nucleus at the onset of S phase. J Cell Sci 2004; 117:465 - 476
  • Rizkallah R, Hurt MM. Regulation of the transcription factor YY1 in mitosis through phosphorylation of its DNA-binding domain. Mol Biol Cell 2009; 20:4766 - 4776
  • Houbaviy HB, Usheva A, Shenk T, Burley SK. Cocrystal structure of YY1 bound to the adenoassociated virus P5 initiator. Proc Natl Acad Sci USA 1996; 93:13577 - 13582
  • Lee JS, Galvin KM, See RH, Eckner R, Livingston D, Moran E, et al. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev 1995; 9:1188 - 1198
  • Yang WM, Inouye C, Zeng Y, Bearss D, Seto E. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci USA 1996; 93:12845 - 12850
  • Caretti G, Di Padova M, Micales B, Lyons GE, Sartorelli V. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev 2004; 18:2627 - 2638
  • Rezai-Zadeh N, Zhang X, Namour F, Fejer G, Wen YD, Yao YL, et al. Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1. Genes Dev 2003; 17:1019 - 1029
  • Deng Z, Wan M, Sui G. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger. Mol Cell Biol 2007; 27:3780 - 3792
  • Minsky N, Oren M. The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. Mol Cell 2004; 16:631 - 639
  • Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer 2007; 120:719 - 733
  • Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004; 4:793 - 805
  • Gill G, Ptashne M. Negative effect of the transcriptional activator GAL4. Nature 1988; 334:721 - 724
  • Castellano G, Torrisi E, Ligresti G, Malaponte G, Militello L, Russo AE, et al. The involvement of the transcription factor Yin Yang 1 in cancer development and progression. Cell Cycle 2009; 8:1367 - 1372
  • Zaravinos A, Spandidos DA. Yin yang 1 expression in human tumors. Cell Cycle 2010; 9:512 - 522
  • Seligson D, Horvath S, Huerta-Yepez S, Hanna S, Garban H, Roberts A, et al. Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol 2005; 27:131 - 141
  • Mousses S, Wagner U, Chen Y, Kim JW, Bubendorf L, Bittner M, et al. Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling. Oncogene 2001; 20:6718 - 6723
  • Buchanan G, Irvine RA, Coetzee GA, Tilley WD. Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Rev 2001; 20:207 - 223
  • Dehm SM, Tindall DJ. Regulation of androgen receptor signaling in prostate cancer. Expert Rev Anticancer Ther 2005; 5:63 - 74